Eduardo Gutierrez - Publications

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.

Journal: Kidney international

Published: February 18, 2026

Delayed kidney response in AL amyloidosis: prevalence and clinical significance.

Journal: Clinical kidney journal

Published: February 04, 2026

Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: November 07, 2025

Chronic kidney disease progression in glomerular diseases: is hematuria a key risk factor?

Journal: Pediatric nephrology (Berlin, Germany)

Published: October 25, 2025

When autosomal dominant polycystic kidney disease becomes atypical: aADPKD.

Journal: Kidney international

Published: October 16, 2025

Avacopan in Double-Positive Vasculitis...Why Not Consider It?: A Case Report.

Journal: Kidney medicine

Published: October 06, 2025

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 25, 2025

Short versus long corticosteroid therapy for immune checkpoint inhibitors-induced acute tubulointerstitial nephritis.

Journal: Clinical kidney journal

Published: September 25, 2025

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 02, 2025

Severe hypertension with thrombotic microangiopathy: the need for pathogenically targeted treatments.

Journal: Kidney international

Published: May 14, 2025